PHR vs WAY
PHR: Phreesia offers an integrated patient intake, engagement, and payment platform that digitizes the healthcare experience for providers and patients. WAY: Waystar provides a cloud-based software platform that automates and optimizes revenue cycle management for healthcare providers.
Side-by-side fundamentals
| Metric | PHR | WAY | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $12.26 | $28.84 | |
| Market cap | $761M | $5.5B | |
| P/E as of 2026-10-21 | 68.11 | 41.20 | WAY lower |
| Net margin | +0.5% | +10.2% | WAY higher |
| Operating margin | -1.4% | +22.7% | WAY higher |
| ROE | +0.7% | +2.9% | WAY higher |
| ROA | +0.3% | +1.9% | WAY higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | n/a | 0.37 | |
| Revenue growth (YoY) | +14.5% | +16.5% | WAY higher |
| Revenue CAGR (3y) SEC XBRL | +19.6% | +16.0% | PHR higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-02 | 0.86 | 0.74 | |
| 1-year return as of 2026-10-21 close | -46.9% | -23.1% | WAY higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.